regeneron semaglutide to test muscle-saving drugs with as weight loss combo Regeneron's Fianlimab Misses Primary Endpoint

Truveta Research shares a new study that explores GLP-1 reinitiation trends and factors following discontinuation.

Hear how GLP-1s actually perform in real-world populations and how they impact costs.

Get expert medical advice at no cost before you begin

Experts cant agree on whether that counts as doping.

It is prescribed

The lack of oversight and ease with which individuals can game the system when there is no in-person or even face-to-face video engagement, nor referral from another healthcare provider, has highlighted the failings in the current prescribing of these powerful medications.[ii] Reports abound of those with a healthy weight, underaged individuals, and those with eating disorders easily getting hold of these so-called skinny jabs